Genomenon, Inc. is a precision medicine company headquartered in Ann Arbor, Michigan, that structures biomedical literature into real-world evidence at the gene and variant level.
Subscribe to see Genomenon’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Genomenon is a biotech company headquartered in Ann Arbor, United States. It has raised at least $34.8M across the 5 funding rounds on record. Its most recent funding round raised $6M in July 2026. Xcout tracks 8 named people at Genomenon, including Mike Klein (Chief Executive Officer). Xcout recorded 3 job postings from Genomenon in the last 90 days, naming tools such as HubSpot, Salesforce.
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for Genomenon, with roles, board committees and tenure — see the full roster →
At least $34.8M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6M | — | |
| SEC Form D filing | $5.5M | — | |
| Series B | $20M | 12 named | |
| SEC Form D filing | $2.9M | — | |
| SEC Form D filing | $446,003 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 3 job postings from Genomenon in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see Genomenon's hiring signals →
A few of Genomenon's closest competitors — see the full list of competitors and alternatives →
gMendel is a medical technology company founded in 2020 that develops an AI-powered, cloud-based platform combining genomics with artificial intelligence. The company provides decision support software designed to enable faster, more accurate, and scalable diagnosis of genetic disorders.
Clarified Precision Medicine is a healthcare company headquartered in San Francisco, California, focused on precision medicine solutions.
Nexome Genomics provides cloud-based, integrated analytics solutions that process next-generation sequencing data for healthcare institutions. The company enables hospitals, medical centers, and physician offices to generate on-demand diagnostic and prognostic reports for precision medicine.
NxGen MDx is a privately held medical consulting and genetic screening company headquartered in Grand Rapids, Michigan, offering specialized laboratory and diagnostic testing services.
FBB Biomed, Inc. provides an RNA analytics platform that uses blood RNA-seq data to quantify real-time gene activity and generate biological signatures for chronic diseases. The company serves diagnostic laboratories seeking to offer novel monitoring tests and biopharmaceutical companies needing tools to stratify clinical trial participants and measure individual responses.
Harmonigenic Corp. is a diagnostics and biotechnology company headquartered in Rochester, New York. The company brings radical innovation to personalized precision medicine, focusing on initial diagnostic and treatment decisions.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Genomenon? Suggest a correction · Work at Genomenon? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.